Related Experiment Videos
[HL-A antigens in bronchogenic carcinoma]
Onkologie
|April 1, 1978
Summary
Human leukocyte antigen (HLA) frequencies differed in bronchogenic carcinoma patients. HLA-A2 decreased while HLA-B8 increased in long-term survivors, suggesting a role in lung cancer prognosis.
Area of Science:
- Immunogenetics
- Oncology
Context:
- Bronchogenic carcinoma (lung cancer) is a significant global health concern.
- Human Leukocyte Antigen (HLA) genes play a crucial role in immune response and are associated with various diseases, including cancer.
Purpose:
- To investigate the association between HLA antigen frequencies and bronchogenic carcinoma.
- To identify potential HLA markers correlating with patient survival in lung cancer.
Summary:
- A study of 37 bronchogenic carcinoma patients revealed a decreased frequency of the HLA-A2 antigen.
- Conversely, an increased frequency of the HLA-B8 antigen was observed in patients who survived longer.
Impact:
- Findings suggest that specific HLA alleles may influence the prognosis of bronchogenic carcinoma.
- Further research into HLA's role could lead to novel immunotherapeutic strategies for lung cancer.